Back to top

Jefferies Reaffirms Their Buy Rating on TG Therapeutics (TGTX)

Jefferies analyst maintained a Buy rating on TG Therapeutics today and set a price target of $83.00. In a report released on June 9, H.C. Wainwrigh...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

TG Therapeutics, Inc. (TGTX)